Convection-enhanced drug delivery to the human brain is a promising method for treating neurodegenerative diseases and brain tumors. Accurate predictions of the drug concentration via computational fluid dynamics models are essential, and models not accounting for diffusion non-Gaussianity give predictions that are not in good enough agreement with experimental results. We use a fluid dynamics model recently presented in the literature, which accounts for diffusion non-Gaussianity, to calculate the differences with models that do not account for it, in data from pre-symptomatic Huntington’s disease patients and metastatic brain tumor patients. We make recommendations on the use of fluid dynamics models in the clinical setting.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords